Cisplatin-induced apoptosis andp53 gene status in a cisplatin-resistant human ovarian carcinoma cell line
Open Access
- 27 September 1996
- journal article
- Published by Wiley in International Journal of Cancer
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Cisplatin Resistance in a Murine Leukemia Cell Line Is Associated with a Defective Apoptotic ProcessExperimental Cell Research, 1995
- Active Efflux System for Cisplatin in Cisplatin‐resistant Human KB CellsJapanese Journal of Cancer Research, 1994
- Programmed cell death (apoptosis) and response to anti-cancer drugsAnti-Cancer Drugs, 1994
- Binding activities ofcis-platin-damage-recognition proteins in human tumour cell linesInternational Journal of Cancer, 1993
- p53, guardian of the genomeNature, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Analysis of Events Associated With Cell Cycle Arrest at G2 Phase and Cell Death Induced by CisplatinJNCI Journal of the National Cancer Institute, 1990
- Pharmacokinetics of free platinum species following rapid, 3-hr and 24-hr infusions of cis-diamminedichloroplatinum (II) and its therapeutic implicationsEuropean Journal of Cancer and Clinical Oncology, 1982
- Mutagenic properties of CIS-Platinum(II)diammino-dichloride in Escherichia coliMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1975